The effect of ropivacaine on pain and nausea after maxillofacial surgery.

Evaluation of the effect of using Ropivacaine injection after surgery in comparison with routine care on pain and nausea after surgery in patients candidate for mandibular orthognathic surgery.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181023041425N2

Enrollment

Registered

2020-10-14

Start date

2020-04-03

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mandibular surgery. Other specified anomalies of jaw-cranial base relationship

Interventions

Intervention 1: Rupivacaine's injection after surgery. Intervention 2: Do not inject Rupivacaine and perform routine care after surgery.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male patients with mandibular defect Examination in the surgical department of Mashhad Dental School and then performing mandibular orthognathic surgery in Ghaem Hospital of Mashhad These patients are ASA-I and ASA-II in terms of systemic classification.

Exclusion criteria

Exclusion criteria: Existence of systemic disease, especially kidney disease The need to use a drug outside the standard protocol of anesthesia or after surgery depending on the patient's condition

Design outcomes

Primary

Measure	Time frame
Postoperative pain and nausea. Timepoint: 1,3,6,12,18,24 Hours after surgery. Method of measurement: using pain and nausea questionnaires.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHoseini Abrishami Majid

Mashhad Dentistry School

HoseiniAbrishamiM@mums.ac.ir+98 51 3882 9501

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026